Amarin Corp Plc (AMRN)

[couldbebetter]

Nuke, The results still being blinded the participants would not yet
know which group they were in. Even if they wanted the medication
only those participants in the US would be able to get it. They
or there insurance would have to pay for it. Maybe some patients in
the US would want to be on Vascepa even without knowing which arm of
the trial they were in...even before results are known...but those
would be very few in number. Maybe the increase in scripts is the
result of the Vascepa commercial's impact. (I saw it for the first
time on CBS yesterday during "Young Sheldon.")